Showing 3431-3440 of 5646 results for "".
- Zeiss Expands Ophthalmic Workflow Portfolio in Canada with Diagnostic, Visualization, and Therapeutic Solutionshttps://modernod.com/news/zeiss-expands-ophthalmic-workflow-portfolio-in-canada-with-diagnostic-visualization-and-therapeutic-solutions/2486373/Key Takeaways Zeiss introduced a broader portfolio of diagnostic devices, therapeutic lasers, and digital workflow tools to enhance eye care deliv
- WCO, Alcon Launch Dry Eye Management Map for Optometrists Worldwidehttps://modernod.com/news/wco-alcon-launch-dry-eye-management-map-for-optometrists-worldwide/2486349/The World Council of Optometry (WCO) and Alcon have launched the Dry Eye Management Map, a new online interactive tool designed to help optometrists evaluate and manage dry eye disease in cl
- Edinburgh Biosciences Showcases Light-Based Cataract Treatment Platform at 100% Optical 2026https://modernod.com/news/edinburgh-biosciences-showcases-light-based-cataract-treatment-platform-at-100-optical-2026/2486017/At the 100% Optical 2026 meeting, Edinburgh Biosciences introduced the SDS-100, the company’s proprietary system designed to deliver its Photon Protein Modulation (PPM) treatment. The exhibition provided the first opportunity f
- International Ophthalmology Study Sheds Light on Myopia Biometry Ahead of Refractive Surgeryhttps://modernod.com/news/international-ophthalmology-study-sheds-light-on-myopia-biometry-ahead-of-refractive-surgery/2485825/Key Takeaways The axial length–to–corneal radius (AL/CR) ratio demonst
- Zeiss Launches Collaborative Care Platform to Enhance Connected Ophthalmic Carehttps://modernod.com/news/zeiss-launches-collaborative-care-platform-to-enhance-connected-ophthalmic-care/2485780/Key Takeaways Zeiss Collaborative Care is designed to enables ECPs to
- FDA Officially Shifts to One-Trial Standard for New Drug Approvalshttps://modernod.com/news/fda-officially-shifts-to-one-trial-standard-for-new-drug-approvals/2485753/The FDA has announced a major change to its regulatory framework, formally establishing that a single well-designed pivotal clinical trial will be the new default basis for most drug and therapeutic approvals—replacing the long-standing expectation that two indepen
- Harrow Launches PharmaPack Direct-to-Prescriber Kits for Ophthalmic Medicationshttps://modernod.com/news/harrow-launches-pharmapack-direct-to-prescriber-kits-for-ophthalmic-medications/2485736/Harrow announced the launch of PharmaPack, a new Direct-to-Prescriber (DTP) cash-pay offering designed to expand access to affordable, FDA-approved branded ophthalmic medications. According to Harrow, by providing transparent,
- LKC Technologies, Provider of Visual Electroretinography, Acquired by AMETEKhttps://modernod.com/news/lkc-technologies-provider-of-visual-electroretinography-acquired-by-ametek/2485723/LKC Technologies announced it has been acquired by Ametek, a provider of industrial technology solutions. Financial terms of the deal were not disclosed. LKC Technologies is the maker of t
- BostonSight Announces Leadership Changes to Advance Ocular Surface Care Worldwidehttps://modernod.com/news/bostonsight-announces-leadership-changes-to-advance-ocular-surface-care-worldwide/2485722/BostonSight announced a 5-year strategic roadmap designed to redefine ocular surface treatment through advancements in clinical research, professional education, and specialty lens technology. As part of the plan, BostonSight announced a new leadership structure ai
- iVeena Doses First Participant in Phase 1 Trial of IVMED-85 for Myopia Progressionhttps://modernod.com/news/iveena-doses-first-participant-in-phase-1-trial-of-ivmed-85-for-myopia-progression/2485668/iVeena Delivery Systems announced that the first patient has been dosed in its phase 1, first-in-human clinical study of IVMED-85 in healthy adult volunteers. The phase 1 trial is designed to evaluate the safety and tolerabili